Dextrose Injection Market Synopsis:
Dextrose Injection Market Size Was Valued at USD 17.40 Billion in 2023, and is Projected to Reach USD 29.64 Billion by 2032, Growing at a CAGR of 6.10% From 2024-2032.
Dextrose Injection market means the global market for sterile intravenous dextrose solution for various applications. These injections are given for energy booster, regulating low blood sugar level, for treatment of electrolyte disorders and nutritional support in patients especially those in hospital and clinic settings.
Continuing increase in the prevalence, particularly of conditions such as diabetes, cancer, cardiovascular diseases has contributed to the increase in the demand for dextrose injections. These conditions require admissions to hospitals and therapies in which patient rely on intravenous fluids for administration of glucose and other nutritional needs. Further, the rising geriatric population, more vulnerable to experienced chronic ailments, plays a major role towards enhancing the market.
Enhance healthcare facilities within the developed and the developing nations have raised the abilities to deliver the critical care treatments such as the administering of dextrose injections. Today’s governments and private sectors are investing a lot of money in modern medical facilities hence an increased uptake and accessibility of those medical solutions. The expansion in healthcare services across the world fosters hard and fast growth in the dextrose injection market.
.webp)
Dextrose Injection Market Trend Analysis:
Increase of Importance of Homecare Solutions
-
This is because pre-filled syringes are easy to use, less hazardous when it comes to the contamination in the syringes and because of the degree of accuracy in the dosing system of the syringes. This trend is more evident in the developed world where technology aspects in injection treatments are defining the new injectables.
- The trends such as home care taking are increasing the demand of dextrose injections that can be administered easily to the patients. As healthcare costs continue to soar, patients as well as the providers seek products that they can administer beyond a hospital environment putting pressure on the development of convenient dextrose injection solutions.
Compatibility with New Product Delivery Systems
-
It is established that various emerging markets in the Asia-Pacific, Latin America and Africa are promising because of their growing expenditures on healthcare systems. Higher levels of knowledge about dextrose injections and better health care access should extend market penetration in these areas.
- The opportunity for combining dextrose injections with a modern approach to delivering substances into the human body, including smart infusion pumps, is very promising. They always enhance precision and rates of recovery among patients thus making more healthcare firms to accept such solutions hence making the market more expansive.
Dextrose Injection Market Segment Analysis:
Dextrose Injection Market Segmented on the basis of Concentrations, Application, End User, and Application.
By Concentrations, 10% Dextrose Injection segment is expected to dominate the market during the forecast period
-
This market is divided by different concentrations that serve various medical requirements of patients. Among them, the 5% and 10% dextrose solutions are employed commonly in clinical practice for mild energy supply and as a maintenance fluid. Concentration above 12.5% especially 25 % and 50% are used in severe conditions like hypoglycemia or electrolyte imbalance conditions. Each concentration provides possible variability with patients while at the same time offering the much-needed medical precision.
By Application, Hypoglycemia Treatment segment expected to held the largest share
-
Dextrose injections’ major uses include treatment of hypoglycemia, wherein it constitutes a source of immediate glucose, correction of electrolyte imbalance, and as fluids; and parenteral nutrition, for provision of energy and fluids to patients who cannot take food in any other manner. These examples of application demonstrate the importance of the market to patients’ healthy state across the therapeutic segments of the market.
Dextrose Injection Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America holds the largest market share in the Dextrose Injection Market because of the enhanced care and attention the region pays to its healthcare centers and a higher rate of chronic diseases. It has full acceptance of post-injection technologies such as pre-filled syringes and state-of-the-art infusion systems in the region. Also, there is an increased government support in the health research and development to sustain market growth.
- The presence of large numbers of players in the pharmaceutical industry and an elaborate network of distribution increases North America’s dominance. In particular, the United States occupies a remarkably large demand for IV gauze for diabetics and the growing number of hospitalizations with the need for intravenous administration of glucose.
Active Key Players in the Dextrose Injection Market:
- B. Braun Melsungen AG (Germany)
- Baxter International (United States)
- Claris Lifesciences (India)
- Fresenius Kabi (Germany)
- Hikma Pharmaceuticals (United Kingdom)
- Hospira Inc. (United States)
- JW Life Science (South Korea)
- Otsuka Pharmaceutical (Japan)
- Pfizer Inc. (United States)
- Sichuan Kelun Pharmaceutical (China)
- Other Active Players
|
Dextrose Injection Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 17.40 Billion |
|
Forecast Period 2024-32 CAGR: |
6.10% |
Market Size in 2032: |
USD 29.64 Billion |
|
Segments Covered: |
By Concentration |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Dextrose Injection Market by Concentration
4.1 Dextrose Injection Market Snapshot and Growth Engine
4.2 Dextrose Injection Market Overview
4.3 5% Dextrose Injection
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 5% Dextrose Injection: Geographic Segmentation Analysis
4.4 10% Dextrose Injection
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 10% Dextrose Injection: Geographic Segmentation Analysis
4.5 25% Dextrose Injection
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 25% Dextrose Injection: Geographic Segmentation Analysis
4.6 50% Dextrose Injection
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 50% Dextrose Injection: Geographic Segmentation Analysis
Chapter 5: Dextrose Injection Market by Application
5.1 Dextrose Injection Market Snapshot and Growth Engine
5.2 Dextrose Injection Market Overview
5.3 Hypoglycemia Treatment
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Hypoglycemia Treatment: Geographic Segmentation Analysis
5.4 Electrolyte Imbalance
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Electrolyte Imbalance: Geographic Segmentation Analysis
5.5 Parenteral Nutrition
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Parenteral Nutrition: Geographic Segmentation Analysis
Chapter 6: Dextrose Injection Market by End User
6.1 Dextrose Injection Market Snapshot and Growth Engine
6.2 Dextrose Injection Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Ambulatory Surgical Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
6.5 Clinics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clinics: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Dextrose Injection Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 BAXTER INTERNATIONAL (UNITED STATES)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 B. BRAUN MELSUNGEN AG (GERMANY)
7.4 FRESENIUS KABI (GERMANY)
7.5 PFIZER INC. (UNITED STATES)
7.6 OTSUKA PHARMACEUTICAL (JAPAN)
7.7 HOSPIRA INC. (UNITED STATES)
7.8 HIKMA PHARMACEUTICALS (UNITED KINGDOM)
7.9 JW LIFE SCIENCE (SOUTH KOREA)
7.10 SICHUAN KELUN PHARMACEUTICAL (CHINA)
7.11 CLARIS LIFESCIENCES (INDIA)
7.12 OTHER ACTIVE PLAYERS
Chapter 8: Global Dextrose Injection Market By Region
8.1 Overview
8.2. North America Dextrose Injection Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Concentration
8.2.4.1 5% Dextrose Injection
8.2.4.2 10% Dextrose Injection
8.2.4.3 25% Dextrose Injection
8.2.4.4 50% Dextrose Injection
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Hypoglycemia Treatment
8.2.5.2 Electrolyte Imbalance
8.2.5.3 Parenteral Nutrition
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Ambulatory Surgical Centers
8.2.6.3 Clinics
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Dextrose Injection Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Concentration
8.3.4.1 5% Dextrose Injection
8.3.4.2 10% Dextrose Injection
8.3.4.3 25% Dextrose Injection
8.3.4.4 50% Dextrose Injection
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Hypoglycemia Treatment
8.3.5.2 Electrolyte Imbalance
8.3.5.3 Parenteral Nutrition
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Ambulatory Surgical Centers
8.3.6.3 Clinics
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Dextrose Injection Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Concentration
8.4.4.1 5% Dextrose Injection
8.4.4.2 10% Dextrose Injection
8.4.4.3 25% Dextrose Injection
8.4.4.4 50% Dextrose Injection
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Hypoglycemia Treatment
8.4.5.2 Electrolyte Imbalance
8.4.5.3 Parenteral Nutrition
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Ambulatory Surgical Centers
8.4.6.3 Clinics
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Dextrose Injection Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Concentration
8.5.4.1 5% Dextrose Injection
8.5.4.2 10% Dextrose Injection
8.5.4.3 25% Dextrose Injection
8.5.4.4 50% Dextrose Injection
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Hypoglycemia Treatment
8.5.5.2 Electrolyte Imbalance
8.5.5.3 Parenteral Nutrition
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Ambulatory Surgical Centers
8.5.6.3 Clinics
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Dextrose Injection Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Concentration
8.6.4.1 5% Dextrose Injection
8.6.4.2 10% Dextrose Injection
8.6.4.3 25% Dextrose Injection
8.6.4.4 50% Dextrose Injection
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Hypoglycemia Treatment
8.6.5.2 Electrolyte Imbalance
8.6.5.3 Parenteral Nutrition
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Ambulatory Surgical Centers
8.6.6.3 Clinics
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Dextrose Injection Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Concentration
8.7.4.1 5% Dextrose Injection
8.7.4.2 10% Dextrose Injection
8.7.4.3 25% Dextrose Injection
8.7.4.4 50% Dextrose Injection
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Hypoglycemia Treatment
8.7.5.2 Electrolyte Imbalance
8.7.5.3 Parenteral Nutrition
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Ambulatory Surgical Centers
8.7.6.3 Clinics
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Dextrose Injection Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 17.40 Billion |
|
Forecast Period 2024-32 CAGR: |
6.10% |
Market Size in 2032: |
USD 29.64 Billion |
|
Segments Covered: |
By Concentration |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
